As Nvidia’s market cap has grown, it has become an increasingly large driver of overall market returns. Nvidia, which holds a ...

With politicians unable to show fiscal restraint it was the bond vigilantes who would impose discipline. As Yardeni put it in ...

The merger injects new life into Platinum ( ASX: PTM ), helping to arrest the organic decline of its business by merging with ...

Oftentimes, stock markets act like a pendulum and swing from overvalued to undervalued and back to overvalued again—and this ...

While pharmaceuticals are still exempt from US tariffs, President Donald Trump has threatened a potential 200% tariff on ...

AI stocks have been more volatile than the overall technology sector, and “the uncertainty is legitimately higher,” Compton ...

For comparison, WiseTech’s closest peers are estimated to have 95% customer retention rates. Although such scores are still ...

Despite no major announcements, shares in Clinuvel Pharmaceuticals ( ASX: CUV) have declined roughly by another 15% since ...

The worst thing that can happen to a retiree is quitting work and having markets plunge and inflation soar. Think of the 4% ...

We’ve seen consumer sentiment recover from the extreme lows of the last few years; conditions are ripe for a retail rebound.

Why it matters: Pro Medicus is accruing contracted revenue slightly faster than our expectations in the key existing academic ...

Tesla’s current product lineup may have reached market saturation. But investors have high hopes its robotaxi business.